{
  "actions": [
    {
      "acted_at": "2014-07-16", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the House Committee on Energy and Commerce.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5124-113", 
  "bill_type": "hr", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }
  ], 
  "congress": "113", 
  "cosponsors": [
    {
      "district": "26", 
      "name": "Burgess, Michael C.", 
      "sponsored_at": "2014-07-16", 
      "state": "TX", 
      "thomas_id": "01751", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2014-07-16", 
  "number": "5124", 
  "official_title": "To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2014", 
  "sponsor": {
    "district": "7", 
    "name": "Davis, Danny K.", 
    "state": "IL", 
    "thomas_id": "01477", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2014-07-16", 
  "subjects": [], 
  "subjects_top_term": null, 
  "summary": null, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2014", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program and to provide for sickle cell disease research, surveillance, prevention, and treatment.", 
      "type": "official"
    }
  ], 
  "updated_at": "2014-08-14T13:35:12-04:00"
}